Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
--
Maximum
Mar 2024
--
Average
--
Median
Mar 2024
Debt to Equity Ratio Benchmarks
| Novartis AG | 0.6999 |
| MEI Pharma Inc | -- |
| Evoke Pharma Inc | 1.140 |
| Revance Therapeutics Inc | -2.645 |
| Vera Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 344.11M |
| Total Liabilities (Quarterly) | 119.44M |
| Shareholders Equity (Quarterly) | 224.67M |
| Current Ratio | 6.562 |